Tetrabenazine Tablet
Product Images NDC 47335-277

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 47335-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-tetrabenazine-figure-1 (Spl Tetrabenazine Figure 1)

This is a graph indicating the Chorea Score changes in patients with HD (Huntington's Disease) treated with Placebo and Tetrabenazine. The study includes 84 patients, 54 of whom were treated with Tetrabenazine, while 30 received Placebo. The Chorea Scores were measured and recorded over a period of 13 weeks (Study Week). There was a significant improvement in patients treated with Tetrabenazine when compared to the Placebo group. There were error bars and the significance level (p-value) is less than 0.05.*

FDA Label Image

Spl-tetrabenazine-figure-2 (Spl Tetrabenazine Figure 2)

This is a graph with two lines indicating the change in the total chorea score of patients in two different treatment groups, Tetrabenazine and Placebo. The graph shows the cumulative percentage of patients on the Y-axis, with specified changes from baseline chorea score on the X-axis. There are two sets of data points for each change in score, one for Tetrabenazine and one for Placebo. The percentages of randomized patients within each treatment group who completed Study 1 are also provided.*

FDA Label Image

Spl-tetrabenazine-label1 (Spl Tetrabenazine Label1)

FDA Label Image

Spl-tetrabenazine-label2 (Spl Tetrabenazine Label2)

Each tablet of this medication contains 25 mg of tetrabenazine. The recommended dosage can be found in the package insert. Store between 20°C to 25°C. Dispense in a child-resistant container and do not use if the seal is missing or broken. Keep out of reach of children. This medication is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Industries Limited in India. The batch number and expiration date are not available.*

FDA Label Image

Spl-tetrabenazine-structure (Spl Tetrabenazine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.